Horizons in Cancer Research presents original research results on the leading edge of cancer. Topics discussed include paclitaxel in chemotherapy and neurotoxicity; the role of prostate-specific antigen (PSA) in pathological angiogenesis and prostate tumour growth; second primary cancer in children and adults; CD133 as a cancer stem cell marker; psychosocial oncology; brain metastases and target therapy for DSB repair deficient tumours; and management of recurrent cervical carcinoma.
Preface; Paclitaxel:: Chemotherapy & Neurotoxicity-The Two Sides of the Coin; Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis & Prostate Tumor Growth; Proteomics in the Discovery of Biomarkers of Chemoresistance:: The Current Status of Paclitaxel Resistance in Human Epithelial Ovarian Cancer; Macromolecules as Paclitaxel Carriers:: From Chemical Considerations to Clinical Applications; Paclitaxel Crystals:: Molecular Interactions, Nucleation & Growth, & Possible Implications on Cell Studies; Second Primary Cancer in Children & Adults:: A Comparison; Critical Evaluation of the Use of CD133 as a Cancer Stem Cell Marker in Solid Tumors; Psychosocial Oncology; Brain Metastases:: Symptoms, Diagnosis & Treatment; Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.